MGTXMeiraGTx Holdings plc

Nasdaq meiragtx.com


$ 5.06 $ -0.03 (-0.59 %)    

Friday, 10-May-2024 15:59:11 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 5.07
$ 5.16
$ 5.05 x 100
$ 0.00 x 0
$ 4.96 - $ 5.16
$ 3.49 - $ 8.35
104,790
na
324.81M
$ 1.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-15-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-26-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 meiragtx-hldgs-q1-eps-032-beats-050-estimate-sales-69700k-down-from-333m-yoy

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.50...

 rbc-capital-reiterates-outperform-on-meiragtx-hldgs-maintains-11-price-target

RBC Capital analyst Luca Issi reiterates MeiraGTx Hldgs (NASDAQ:MGTX) with a Outperform and maintains $11 price target.

 recap-meiragtx-hldgs-q4-earnings
Recap: MeiraGTx Hldgs Q4 Earnings
03/14/2024 21:50:07

Core News & Articles

MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the achievem...

 why-carmax-shares-are-trading-higher-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

 why-is-eye-disease-related-gene-therapy-focused-meiragtx-stock-soaring-today

MeiraGTx Holdings plc (NASDAQ: MGTX) on Thursday announced an asset purchase agreement with Janssen Pharmaceuticals Inc, a John...

 meiragtx-hldgs-q3-eps-074-misses-055-estimate-sales-510m-beat-327m-estimate

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0....

 why-on-semiconductor-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire...

 why-is-gene-therapy-company-meiragtx-stock-trading-higher-today

MeiraGTx Holdings plc (NASDAQ: MGTX) shares are trading higher after French pharma giant Sanofi SA (NASDAQ: SNY) made a $30 mil...

 meiragtx-announces-an-oral-presentation-and-eight-posters-at-the-european-society-of-gene-and-cell-therapy-2023-annual-congress

MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company ...

 rbc-capital-maintains-outperform-on-meiragtx-hldgs-lowers-price-target-to-11

RBC Capital analyst Luca Issi maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Outperform and lowers the price target from $13 ...

 chardan-capital-reiterates-buy-on-meiragtx-hldgs-maintains-41-price-target

Chardan Capital analyst Geulah Livshits reiterates MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and maintains $41 price target.

 meiragtx-hldgs-q2-eps-053-up-from-076-yoy-sales-354m-down-from-1076m-yoy

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.53) per share. This is a 30.26 percent increase over losses of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION